Peter Lee, MD
Neurological Surgery · Seattle, WANPI 1710143698
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,180 of the $4,852 with a category attached, or 65.5%. Globus Medical accounts for 68.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,066 and has fallen 97.3% since, to $56 in 2025.
Across 42 payments — averaging $115.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$3K
- Arthrex$322
- Medtronic$244
- Si-bone, Inc.$190
- Richard Wolf Medical Instruments Corp.$166
- Johnson & Johnson$158
- plus $427 from 6 others
What the payments were for
- Travel & lodging$3,18066%
- Food & beverage$1,67234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 16 | $3,345 |
| Arthrex | 2 | $322 |
| Medtronic(2 entities) | 7 | $244 |
| Si-bone, Inc. | 3 | $190 |
| Richard Wolf Medical Instruments Corp. | 2 | $166 |
| Johnson & Johnson | 3 | $158 |
| Alphatec Spine, Inc | 2 | $158 |
| Amplify Surgical, Inc. | 1 | $121 |
| Invictus Surgical Incorporated | 2 | $60 |
| Medical Device Business Services, Inc. | 2 | $32 |
| Blueprint Medicines Corporation | 1 | $29 |
| Bayer | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE-L$1,233
- ExcelsiusGPS Robotic Navigation System$968
- XLIF$620
- Pulse$194
- ALTERA$137
- KODIAK$128
- dualX and DualPortal$121
- MAZOR X SYSTEM$111
How this compares
$4,852 in reported general payments places this provider in the 65th percentile of 175 neurological surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 20 | $234 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Seattle
- Rod OskouianSeattle$2.4M
- Christoph HofstetterSeattle$768K
- Stephen MonteithSeattle$151K
- Jean-Christophe LevequeSeattle$120K
- Vijay YanamadalaSeattle$85K
- Hoan Vu TranSeattle$78K
- Martin RutkowskiSeattle$62K
- Bailey ZampellaSeattle$38K
- Melanie WalkerSeattle$38K
- Elias EliasSeattle$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.